Medical dissolution of presumptive upper urinary tract struvite uroliths in 6 dogs (2012-2018)
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17204 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Sindumani A Manoharan and 4 co-authors. Institution: Department of Diagnostic Imaging and Interventional Radiology, The Animal Medical Center, New York, New York, USA. Major MEDLINE topics: Dog Diseases, Struvite, Stents, Anti-Bacterial Agents. Cited 2 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Minimally invasive approaches are the standard for treatment of upper urinary tract uroliths in humans.
Objective
To describe the medical dissolution of upper urinary tract uroliths in a series of dogs and report clinical outcomes. Animals 6 female dogs (9 kidneys).
Methods
Retrospective case series. A review of medical records in dogs that underwent medical dissolution of upper urinary tract uroliths utilizing diet, administration of antibiotics, and double-pigtail ureteral stent(s) placement, when indicated, was performed. Medical management was generally continued for 4 weeks beyond urolith dissolution. Information on biochemical, microbiological, imaging, and clinical outcomes before and after dissolution were recorded.
Results
Six dogs (9 kidneys) were included with bilateral (3) or unilateral (3) nephrolithiasis, ureterolithiasis, or a combination. A ureteral stent(s) was placed endoscopically in 5/6 dogs (6/9 kidneys) for obstructive ureterolithiasis (n = 5) or a nonobstructive massive nephrolith (n = 1). All dogs had a positive urine culture of Staphylococcus pseudintermedius with a median urine pH of 7.25 (range, 6.5-8) and 4/5 had pyonephrosis. All dogs had initial evidence of urolith dissolution at a median of 1.1 months (range, 0.42-5.9), with complete dissolution of ureteroliths at a median of 3.9 months (range, 1.5-7.6), nephroliths at 5.3 months (range, 1.5-7.6), and lower urinary tract uroliths at 0.87 months (range, 0.42-5.9). Stents were removed in 3/6 once dissolution was documented. The median follow-up time was 519 days (range, 177-2492 days). Conclusion and Clinical Importance Medical dissolution and decompression of upper urinary tract struvite uroliths should be considered a minimally invasive treatment for dogs before more invasive options.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Diagnostic Imaging and Interventional Radiology, The Animal Medical Center, New York, New York, USA.
- Department of Urology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
ORCID profiles: Sindumani A Manoharan, Chick W Weisse
Cite
APA
Manoharan, S. A., Berent, A. C., Weisse, C. W., Purdon, K., & Bagley, D. (2024). Medical dissolution of presumptive upper urinary tract struvite uroliths in 6 dogs (2012-2018). Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17204
Vancouver
Manoharan SA, Berent AC, Weisse CW, Purdon K, Bagley D. Medical dissolution of presumptive upper urinary tract struvite uroliths in 6 dogs (2012-2018). Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17204
BibTeX
@article{Manoharan2024,
author = {Manoharan, Sindumani A and Berent, Allyson C and Weisse, Chick W and Purdon, Kira and Bagley, Demetrius},
title = {Medical dissolution of presumptive upper urinary tract struvite uroliths in 6 dogs (2012-2018)},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17204}
}
EUVIMED